It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Activation of the inflammasome is involved in the progression of retinal degenerative diseases, in particular, in the pathogenesis of Age-Related Macular Degeneration (AMD), with NLRP3 activation the focus of many investigations. In this study, we used genetic and pharmacological approaches to explore the role of the inflammasome in a mouse model of retinal degeneration. We identify that Casp1/11−/− mice have better-preserved retinal function, reduced inflammation and increased photoreceptor survivability. While Nlrp3−/− mice display some level of preservation of retinal function compared to controls, pharmacological inhibition of NLRP3 did not protect against photoreceptor cell death. Further, Aim2−/−, Nlrc4−/−, Asc−/−, and Casp11−/− mice show no substantial retinal protection. We propose that CASP-1-associated photoreceptor cell death occurs largely independently of NLRP3 and other established inflammasome sensor proteins, or that inhibition of a single sensor is not sufficient to repress the inflammatory cascade. Therapeutic targeting of CASP-1 may offer a more promising avenue to delay the progression of retinal degenerations.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Nilisha, Fernando 2 ; Wong, Josephine H, C 2
; Dietrich, Catherine 2 ; Aggio-Bruce Riemke 2 ; Chu-Tan, Joshua A 1 ; Robertson Avril A B 3
; Doyle, Sarah L 4 ; Man Si Ming 2
; Natoli Riccardo 1
1 The Australian National University, The John Curtin School of Medical Research, Canberra, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477); The Australian National University, The ANU Medical School, Canberra, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477)
2 The Australian National University, The John Curtin School of Medical Research, Canberra, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477)
3 The University of Queensland, School of Chemistry and Molecular Bioscience, St. Lucia, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
4 School of Medicine, Trinity College Institute of Neuroscience, Trinity College, Department of Clinical Medicine, Dublin, Ireland (GRID:grid.8217.c) (ISNI:0000 0004 1936 9705); Our Lady’s Children’s Hospital Crumlin, The National Children’s Research Centre, Dublin, Ireland (GRID:grid.417322.1) (ISNI:0000 0004 0516 3853)




